Venus Concept Inc. to Participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 17th

Rhea-AI Summary

Venus Concept, a leader in medical aesthetic technology, announced its participation in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 17, 2021, at 10:00 a.m. Eastern Time.

The engagement will feature a virtual fireside chat, accessible via an audio webcast on the Company’s investor relations website. Post-event, an archive of the webcast will be available for replay. Venus Concept specializes in minimally invasive aesthetic technologies and has operations in over 60 countries.

TORONTO, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that management will participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference.

Management will participate in a virtual fireside chat at the conference on Wednesday, February 17th at 10:00 a.m. Eastern Time.

An audio webcast of the fireside chat will be accessible under the “Events” section of the Company's investor relations website at https://ir.venusconcept.com/. An archive of the webcast will be available for replay following the conference.

About Venus Concept

Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reach in over 60 countries and 21 direct markets. Venus Concept focuses its product sales strategy on a subscription-based business model in North America and in its well-established direct global markets. Venus Concept’s product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Legacy, Venus Velocity, Venus Fiore, Venus Viva, Venus Freeze Plus, Venus Heal, Venus Glow, Venus Bliss, Venus Epileve and Venus Viva MD. Venus Concept’s hair restoration systems includes NeoGraft®, an automated hair restoration system that facilitates the harvesting of follicles during a FUE process and the ARTAS® and ARTAS iX® Robotic Hair Restoration systems, which harvest follicular units directly from the scalp and create recipient implant sites using proprietary algorithms. Venus Concept has been backed by leading healthcare industry growth equity investors including EW Healthcare Partners (formerly Essex Woodlands), HealthQuest Capital, Longitude Capital Management, and Aperture Venture Partners.

FAQ

When is Venus Concept participating in the BTIG conference?

Venus Concept will participate in the BTIG Virtual MedTech Conference on February 17, 2021, at 10:00 a.m. Eastern Time.

How can I access the Venus Concept fireside chat?

The fireside chat can be accessed through the audio webcast available on Venus Concept's investor relations website.

What does Venus Concept focus on?

Venus Concept focuses on innovative medical aesthetic technologies and offers a range of minimally invasive and non-invasive products.

What is the stock symbol for Venus Concept?

The stock symbol for Venus Concept is VERO.

What technologies does Venus Concept provide?

Venus Concept provides aesthetic devices and hair restoration systems, including the NeoGraft and ARTAS robotic systems.